Changchun High-Tech Industry (Group)
Changchun High & New Technology Industry (Group) Inc is a Chinese biotechnology and pharmaceutical enterprise headquartered in Changchun, Jilin Province, China. The company specializes in the research, development, manufacturing, and distribution of biopharmaceuticals, recombinant human growth hormones, vaccines, and traditional Chinese medicines. Principal revenue is derived through wholesale manufacturing sales of proprietary pharmaceutical products and biological formulations to hospitals and medical institutions. Changchun High & New Technology Industry is publicly listed on the Shenzhen Stock Exchange.
3 of the funds FundTelligence covers report a position in Changchun High-Tech Industry (Group).
- Legal name
- Changchun High-Tech Industry (Group) Co Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 3
Funds holding Changchun High-Tech Industry (Group)
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.02 % (full portfolio disclosed, September 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- KLP AksjeFremvoksende Markeder Indeks — KLP · 0.0 % (full portfolio disclosed, June 2026)